A multi-cycle open label study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
| Autor: | Minic, P., Fustic, S., Solyom, E., Mazurek, H., Antipkin, Y., Feketova, A., Senatorova, A., Csiszer, E., Kostromina, V., Takac, B., Ujhelyi, R., Gupta, R. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis 2010 9 Supplement 1:S61-S61 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect